Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

Circassia appoints new head to its Board of directors

December 6, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Circassia

Speciality biopharma firm Circassia has announced the appointment of Dr Jean-Jacques Garaud to its Board of directors. Garaud has extensive …
Appointment
hans_008_4189455_rohde_hans

uniQure appoints Basilea’s chief commercial officer

December 6, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Basilea, uniQure

Dutch human gene therapy firm uniQure has appointed Hans Christian Rohde as chief commercial officer. Rohde joins uniQure from Basilea …
Appointment
screen_shot_2012-12-05_at_10

ImmunoCellular appoints Andrew Gengos as chief executive

December 5, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Gengos, ImmunoCellular

Clinical stage firm ImmunoCellular Therapeutics has announced the appointment of Andrew Gengos as president and chief executive and member of …
Appointment
Bayer image

New boost for drug candidates

December 5, 2012 Research and Development, Sales and Marketing Bayer, EFPIA, K4DD, Leiden

A new project is trying to increase the hit rates of successful drug candidates by improving the way they are …
News

Trajenta may reduce stroke damage

December 4, 2012 Research and Development, Sales and Marketing Boehringer, EMA, Trajenta, diabetes, linagliptin

Boehringer Ingelheim’s  diabetes drug Trajenta could one day be used to minimise the effects of brain damage following stroke. Scientists …
News

R&D costs rise ten-fold

December 4, 2012 Research and Development, Sales and Marketing OHE, R&D, research and development

Research by the Office of Health Economics (OHE) think tank shows that the cost of pharma R&D has risen ten-fold …
News

J&J’s Alex Gorsky to be chairman and chief executive

December 3, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Johnson & Johnson has has elected its chief executive Alex Gorsky to be its chairman of the Board of directors.  …
Appointment
mr_subhanu_saxena__1276617e

New chief executive for Cipla

November 30, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Cipla, Subhanu Saxena

Indian pharma firm Cipla has announced the appointment of Novartis’ Subhanu Saxena as its chief executive. Saxena joins Cipla in …
Appointment
Novartis image

Novartis R&D warning

November 29, 2012 Research and Development, Sales and Marketing NHS, Novartis. R&D, trials

Novartis has hit out at what it sees as the high cost of UK clinical trials, warning that business will …
News
screen_shot_2012-11-28_at_15

Genzyme appoints new GM for UK and Ireland

November 29, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brendan Martin, Genzyme

Genzyme has announced the appointment of Brendan Martin as general manager for UK and Ireland. Martin will be responsible for …
Appointment

Survey: pharma losing $564 billion each year

November 28, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cap Gemini, Health Prize, pharma

Pharma companies are losing $564 billion each year – more than half the industry’s $956 billion revenue worldwide last year …
News
screen_shot_2012-11-27_at_13

RSA welcomes new starter

November 28, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huberts, rsa

Life Sciences Executive Search and Interim Management specialists RSA, has announced that Michael Huberts has joined the UK business as …
Appointment
EMA image

EMA’s five points on data release

November 27, 2012 Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Rasi, transparency

The European Medicines Agency has highlighted five areas that need to be ironed out before it begins publishing clinical trial …
News
post-stephen-hill-targacept280

Targacept confirms Stephen Hill as president and chief executive

November 27, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targacept, stephen hill

Clinical-stage biopharma firm Targacept has announced that Stephen Hill has been appointed as president and chief executive. Hill is expected …
Appointment
jim_mellon

Summit appoints two non-executive directors

November 26, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Frank Armstrong, Jim Mellon, summit

UK drug discovery and development firm Summit has appointed Jim Mellon and Dr Frank Armstrong as non-executive directors. The additions …
Appointment
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026